Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
5
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
5
×
wisconsin blog main
wisconsin top stories
boston top stories
cancer
novartis
startups
abbvie
allergan
biogen
clinical trials
crispr
eli lilly
europe blog main
europe top stories
What
bio
roundup
covid
drugs
fda
ipo
life
medicines
new
science
acquisitions
activity
announced
approvals
august
bails
biogen
biotech
black
brand
bridgebio
busy
capital
car
ceo
clamped
collabs
companies
continue
daniel
days
deal
debut
decisions
delays
develop
developing
devices
diamond
diamond’s
Language
unset
5
×
Current search:
ipo
×
unset
×
" texas top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
